Tools
Stock profile

Alphatec Holdings, Inc. (ATEC)

ATEC · Latest close $7.06 as of Nov 18, 2026 · 13F data as of Jun 30, 2026 (2026 Q2)
Latest close
$7.06
As of Nov 18, 2026
Tracked funds holding
1 of 149
2026 Q2 13F filings
Opened / added
0 / 1
vs previous quarter
Trimmed / exited
0
vs previous quarter

Alphatec Holdings, Inc. (ATEC) is held by 1 of 149 tracked super-investor funds (144 filed in Q2) in 2026 Q2 13F filings, with 1 fund adding versus the previous quarter. Insiders were net buyers over the last 90 days ($1.8M bought vs $0 sold). Latest close $7.06 as of Nov 18, 2026.

Data as of Nov 18, 2026 (prices) · 2026 Q2 13F filings (quarter ended Jun 30, 2026) · Latest Form 4: Nov 16, 2026 · Congress to Nov 16, 2026.

Funds
2026 Q2 13F
Insiders · 90d
net $1.8M
Fundamentals
Revenue · FY2025
Red flags
none flagged
Short interest
as of Oct 15, 2026
Holdings · Charts · All institutions · Fundamentals · Short interest · Fails to deliver · Insider trading · 5% holders · Planned sales · Politician trading · Committee jurisdiction · Screens & lenses · Signal record · Related stocks · Recent 8-K

Funds holding this

First Eagle Investment Management — 1 tracked fund hold ATEC. See all holders.

Insider and Congress activity

Insiders bought on the open market (4 purchases, $1.8M) vs 0 sales ($0). Latest buy: Nov 16, 2026. Insider trading

Often held alongside

BECTON DICKINSON & CO (BDX) · BOSTON SCIENTIFIC CORP (BSX) · BAXTER INTERNATIONAL INC (BAX) · STRYKER CORP (SYK) · Solventum Corp (SOLV) — stocks the same funds also hold. See all related stocks.

Super-investor holdings · 2026 Q2

FundPortfolio weightSharesChange vs prev. quarter
First Eagle Investment Management0.01%996,637ADDED (+43.1%) Q3 filed Nov 10

Source: SEC Form 13F filings, quarter ended Jun 30, 2026. Change labels compare each fund’s 2026 Q2 filing with its previous filing. Fund counts aggregate every share class mapped to this ticker.

Price change since quarter-end: -21.7% from the close on the first trading day after the quarter ended (Jul 1, 2026) to the latest close (Nov 17, 2026). 13F does not report purchase prices — this is the price change since the quarter-end close, not a gain on any fund’s actual purchase.

Filing season: the Q3 2026 13F tracker follows every tracked fund’s filing for the quarter ended Sep 30, 2026, with its biggest buys and sells.

Charts

22.686.142024-11-192026-11-18

Closing prices (unadjusted for dividends), last 2 years — 501 trading days to Nov 18, 2026. Dashed lines mark 13F filing deadlines. Source: Yahoo Finance daily bars.

All institutions · Form 13F

Institutions holding266 of 8,857 filers
Long-only filers among them266
Change vs 2026 Q1-12 net · 253 entered · 265 exited
Shares reported, all filers111,489,871
Reported value, all filers$1.0B

Source: SEC Form 13F data sets — every filer's latest report for the quarter ended Jun 30, 2026, not just the tracked funds above; changes compare with the quarter ended Mar 31, 2026. Share counts and values are summed as reported in the filings (a small number of filers report values in thousands of dollars, so value totals are as-filed sums).

Company fundamentals

ExchangeNasdaq
IndustrySurgical & Medical Instruments & Apparatus (SIC 3841)
Revenue · FY2025$764.2M
Net income · FY2025$-143.4M
Total assets · FY2025$791.2M
Shares outstanding155,139,824
Market cap (at latest close)$1.1B

Source: SEC EDGAR company filings (submissions and company facts), collected Oct 30, 2026. Shares outstanding as reported Oct 22, 2026.

Short interest

Shares short · Oct 15, 202613,283,446
Share of shares outstanding8.56%
Days to cover5.86

Shares short at recent settlements — Jul 31, 2026: 13.8M · Aug 14, 2026: 13.6M · Aug 31, 2026: 13.7M · Sep 15, 2026: 14.4M · Sep 30, 2026: 14.1M · Oct 15, 2026: 13.3M.

Source: FINRA Equity Short Interest (biweekly settlement data). Shares outstanding from SEC filings as of Oct 22, 2026.

Fails to deliver

Shares failed to deliver · Oct 14, 20260
Share of shares outstanding0.00%
Fails as a share of short interest · Oct 15, 20260.0%

Fails to deliver at recent settlements — Jul 31, 2026: 0 · Aug 14, 2026: 0 · Aug 31, 2026: 14 · Sep 15, 2026: 0 · Sep 30, 2026: 0 · Oct 14, 2026: 0.

Source: SEC Fails-to-Deliver data (semi-monthly files, published about two weeks after each settlement date). Each figure is the balance of shares not yet delivered on that date; a stock absent from that date’s file counts as zero. See our research on whether fails to deliver predict returns. Shares outstanding from SEC filings as of Oct 22, 2026.

Insider trading · Form 4

4 insiders bought on the open market in the last 90 days (4 purchases, $1.8M), against 0 sales by 0 insiders ($0). Latest buy: Nov 16, 2026.

CEO/CFO bought$1M+ open-market buy

Source: SEC Form 4 filings. Open-market transactions only.

Recent open-market trades

DateInsiderRoleBuy / SellSharesPriceValueSource
Nov 16, 2026Koning John ToddCHIEF FINANCIAL OFFICERBuy14,601.7699$6.79$99.1KSEC filing
Nov 10, 2026Valentine KeithBuy35,000$6.93$242.6KSEC filing
Oct 30, 2026Demski David MBuy60,000$6.81$408.6KSEC filing
Sep 10, 2026Miles PatrickCEOBuy115,000$8.81$1.0MSEC filing

Most recent open-market transactions in the same 90-day window, most recent first. Source: SEC Form 4 filings.

Planned sales · Form 144

FiledSellerRoleShares to sellMarket valueApprox. sale dateSource
Aug 5, 2026TYSON MARSHALLOfficer8,168$84.5KAug 5, 2026SEC filing
Jun 11, 2026MCGINNIS KAREN KDirector6,050$48.5KJun 11, 2026SEC filing
Mar 13, 2026JOHN TODD KONINGOfficer79,789$997.4KMar 13, 2026SEC filing
Mar 13, 2026SCOTT LISHOfficer260,535$3.2MMar 13, 2026SEC filing
Mar 11, 2026DAVID SPONSELOfficer163,452$2.0MMar 11, 2026SEC filing
Mar 6, 2026Craig Hunsakerofficer95,000$1.2MMar 6, 2026SEC filing
Mar 5, 2026TYSON MARSHALLOfficer88,835$1.2MMar 5, 2026SEC filing
Feb 5, 2026DAVID SPONSELOfficer60,425$849.6KFeb 5, 2026SEC filing
Feb 3, 2026Craig Hunsakerofficer37,358$548.2KFeb 3, 2026SEC filing
Jan 5, 2026PATRICK MILESDirector, Officer300,000$6.2MJan 5, 2026SEC filing

A Form 144 notice is a planned sale, not a completed sale. Most recent first. Source: SEC Form 144 filings, 63,013 notices from Apr 13, 2023 to Oct 9, 2026.

Activist disclosure · Schedule 13D

FiledFormPrice change since disclosure
Dec 17, 2025SCHEDULE 13D/A-65.1% (close Dec 18, 2025 → Nov 17, 2026)

Reference close is the first trading day after the filing (Dec 18, 2025). A Schedule 13D reports beneficial ownership, not a purchase — there is no transaction price to show. Source: SEC EDGAR Schedule 13D filings.

5% holders · Schedule 13D/G

FiledFilerFormShares% ownedEvent dateSource
Dec 17, 2025Squadron Capital LLCSC 13D/A10,395,0457.0%Dec 15, 2025SEC filing
Apr 23, 2025L-5 Healthcare Partners, LLCSC 13D/A7,201,1585.0%Apr 23, 2025SEC filing
Apr 11, 2025L-5 Healthcare Partners, LLCSC 13D/A7,699,3155.3%Apr 9, 2025SEC filing
Feb 6, 2025L-5 Healthcare Partners, LLCSC 13D/A9,214,6986.5%Feb 4, 2025SEC filing

One filing is one row; a filing may list several reporters and the first is shown. Figures are as filed, including amendments that report zero shares after a transfer. Source: SEC Schedule 13D/G filings, 57,443 filings parsed to Oct 2, 2026.

Politician trading · U.S. Congress

Data unavailable — no congressional STOCK Act transactions for this ticker were parsed in the current window (as of Nov 16, 2026).

Committee jurisdiction

Industry: Surgical & Medical Instruments & Apparatus (SIC 3841). Standing committees with jurisdiction over this industry: Senate Committee on Health, Education, Labor, and Pensions, House Committee on Energy and Commerce.

None of the members who traded this stock in the current window sit on these committees.

Assignments are the current (119th Congress) rosters. A trade made in an earlier Congress may have been made under a different assignment. Jurisdiction is by industry (SEC SIC code), not by anything the company said or did. Same rule as our committee-jurisdiction study.

Screens & lenses

Insiders

· Insider Cluster Buying — Last 90 days: 3 or more different insiders bought on the open market

· CEO & CFO Buying — Last 90 days: top executives (CEO/CFO) bought on the open market

· Large Insider Buys — Last 90 days: a single buy trade of $1M or more

· Insider Net Buying — Last 90 days: more insider buy transactions than sell transactions

Financial Screens

· Gross Profitability (Novy-Marx) — High gross profit relative to total assets

Key figures

· Gross Profitability (Novy-Marx) — Gross profit / assets: 80.6% · Gross margin: 67.1%

· Insider Cluster Buying — Insiders buying: 4 · Buy txns: 4 · Buy value: $1.8M · Latest buy: Nov 16, 2026

· CEO & CFO Buying — Buy txns: 4 · Buy value: $1.8M · Insiders buying: 4 · Latest buy: Nov 16, 2026

· Large Insider Buys — Buy value: $1.8M · Buy txns: 4 · Insiders buying: 4 · Latest buy: Nov 16, 2026

· Insider Net Buying — Buy txns: 4 · Sell txns: 0 · Buy value: $1.8M · Latest buy: Nov 16, 2026

Financial screens are computed from SEC company financial statements; red-flag models are screens, not verdicts — see Methodology.

Signal record

· Insider BEST — appeared in 4 of the last 20 quarterly lists; latest 2024 Q3, ranked #16 of 50.

Also held by the tracked funds that hold ATEC — ranked by lift, the co-holding pattern described in Methodology: BECTON DICKINSON & CO (BDX) · BOSTON SCIENTIFIC CORP (BSX) · BAXTER INTERNATIONAL INC (BAX) · STRYKER CORP (SYK) · Solventum Corp (SOLV) · Medline Inc. (MDLN) · 3M CO (MMM) · WEST PHARMACEUTICAL SERVICES INC (WST).

8 of the 8 are same-industry (SIC) fillers: fewer than 4 stocks met the lift rule for this stock.

Recent 8-K filings

FiledItemsSource
Oct 29, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Aug 4, 20262.02 Results of Operations and Financial Condition · 9.01 Financial Statements and ExhibitsSEC filing
Jun 11, 20265.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers · 5.07 Submission of Matters to a Vote of Security Holders · 9.01 Financial Statements and ExhibitsSEC filing

Source: SEC EDGAR Form 8-K filings, latest first. Amendments (Form 8-K/A) are labeled as such. Item labels are the SEC's item titles; a filing can carry several items. Item 5.02 covers both departures and appointments, which this index does not distinguish.

Related

BECTON DICKINSON & CO (BDX) · Track Record: how the signals scored · Practice timing on ATEC

One email a week: the week’s new filings and research. Subscribe free

← ATAT  ·  ATHM →

Open the interactive tool →Live screens, charts and backtests for every tracked stock, fund and signal — free, no sign-up.